Fortitude Family Office’s MacroGenics MGNX Stock Holding History

Fortitude Family Office’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.06K	Hold	276	–	–	﹤0.01%	2229
2026 Q2	$1.27K	Hold	276	–	–	﹤0.01%	1662
2026 Q1	$798	Buy	+276	New	+$589	﹤0.01%	1569
2024 Q3	–	Sell	-455	Closed	-$1.93K	–	1247
2024 Q2	$1.93K	Sell	455 -279	-38%	-$2.72K	﹤0.01%	813
2024 Q1	$10.8K	Hold	734	–	–	0.01%	380
2023 Q4	$7.06K	Buy	+734	New	+$5.07K	0.01%	500

Other funds holding MGNX

Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

SMH

Sanders Morris Harris Houston, Texas $755M AUM 11.28% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Fortitude Family Office's MGNX Position: Q3 2026 in Review

Fortitude Family Office held its MacroGenics (MGNX) position steady in Q3 2026 at 276 shares worth $1.06K. The position accounts for ﹤0.01% of the portfolio, ranked #2229.

Fortitude Family Office first reported a position in MGNX in Q4 2023 and has held it in 6 quarters since. The position peaked at $10.8K in Q1 2024. 5 funds tracked by Wall St. Rank hold MGNX as of Q3 2026.

Fortitude Family Office held 276 shares of MacroGenics worth $1.06K as of Q3 2026.
Fortitude Family Office left its MacroGenics share count unchanged in Q3 2026.
MacroGenics made up ﹤0.01% of Fortitude Family Office's portfolio in Q3 2026, its #2229 holding.
Fortitude Family Office first reported a position in MacroGenics in Q4 2023 and has held it in 6 quarters since.
Fortitude Family Office's MacroGenics position peaked at $10.8K in Q1 2024.
5 funds tracked by Wall St. Rank held MacroGenics as of Q3 2026.

Based on Fortitude Family Office's 13F filing for Q3 2026, filed 14 Oct 2026.